Braxia Scientific Corp (OP: BRAXF )

0.0027 UNCHANGED

Streaming Delayed Price Updated: 3:53 PM EDT, Oct 31, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Braxia Scientific Corp

< Previous 1 2 Next >

I Saw Trillions Of Atoms In My Hand Vibrating At A Certain Frequency, Says Zappy Zapolin Describing His First Psychedelics Experience

August 13, 2024

Via Benzinga

Psychedelics Headlines: Predicting Readiness, Correcting The Hype, Good And Bad Drugs, Training Programs And More

March 01, 2024

Via Benzinga

Podcast - Post-Frenzy Psychedelics Investing And Reclaiming The Right To Pursue Happiness With Zappy Zapolin: '2024 Is When It Goes Mainstream'

February 29, 2024

Via Benzinga

Psyched: John Lennon Remembered, Clinical Trials For Service Members, Chrissy Teigen, Jon Feliciano And More

December 11, 2023

John Lennon Remembered 43 Years After His Murder In New York, Psychedelic Adventures & Enduring Legacy

Via Benzinga

Braxia Scientific's Q2 2024: Cash Burn Over But Income Low, What's Next For Psychedelics Company?

December 04, 2023

Ontario-based Canadian psychedelics company Braxia Scientific Corp. (OTC Pink: BRAXF) filed its interim financial statements and management discussion for the three and six months ended Sept. 30,...

Via Benzinga

Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More

September 05, 2023

Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety

Via Benzinga

Braxia Scientific Faces Challenges In Accessing Public Market Capital, Reports Q1 Loss

August 31, 2023

Braxia Scientific Corp.

Via Benzinga

Psyched: Dubai Psychedelics Event, Key Receptor Discovered, Drew Barrymore, Oprah's Guest, Swiss MDMA & More

June 13, 2023

Science Conference In Dubai, UAE Hosts Discussion On Psychedelics Research

Via Benzinga

BetterLife's Non-Hallucinogenic LSD's Clinical Studies, Braxia's Psychedelic Treatments Continue

June 09, 2023

Psychedelics biotech BetterLife Pharma (OTCQB: BETRF) announced its non-hallucinogenic LSD derivative, BETR-001, is progressing through IND-enabling studies toward expected clinical studies targeting...

Via Benzinga

Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More

March 20, 2023

Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered

Via Benzinga

Major Ketamine Clinics Chain Decides Not To Pursue Acquisition Deal

March 16, 2023

Irwin Naturals Inc.

Via Benzinga

Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More

March 07, 2023

Psychedelics Bills Around The Country: 9 New Proposals, Several Passes, Several Fails And A Successful Local Decriminalization Throughout the 2023 session, numerous discussions have been...

Via Benzinga

Braxia Scientific's Q3 2023 Finances, Update On Upcoming Acquisition With Irwin Naturals

March 02, 2023

Research and telemedicine company Braxia Scientific Corp. (OTC: BRAXF) has filed its financial statements for the third quarter ended Dec.

Via Benzinga

Irwin Naturals Acquires Ketamine Clinic In Kentucky Adding $3M In Projected EBITDA

February 21, 2023

Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA:97X) has successfully completed the acquisition of Serenity Health, LLC, a ketamine clinic in Louisville, KY. The agreement with Serenity was...

Via Benzinga

Irwin Naturals Signs LOI To Acquire Braxia Scientific Expanding Its Network Of Mental Health Clinics

January 27, 2023

Irwin Naturals Inc.

Via Benzinga

6 Psychedelics Companies Take Action: Here Are The Latest, Major Announcements

January 10, 2023

Second week of 2023, and business is up and running. Let’s take a look at the announcements shared by some of the companies in the psychedelics space.

Via Benzinga

Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project

December 06, 2022

Psychedelic Research & Fed Funding By The National Institute Of Mental Health The National Institute of Mental Health (NIMH) named the types of psychedelics studies to which it would grant funds and...

Via Benzinga

Braxia Scientific Q2 2023 Financial Results: Health Clinic Ketamine Treatments Increases 34.5% YoY

December 01, 2022

Braxia Scientific Corp., (CSE: BRAX) (OTC: BRAXF) (FWB: 4960), a medical research and telemedicine company with clinics providing innovative ketamine and psilocybin treatments for depression and...

Via Benzinga

Psyched: CA's Psychedelic-Assisted Treatments, Ketamine Therapy, Near-Death Experience And More

October 07, 2022

Alberta Becomes The First Canadian Province To Regulate Psychedelics-Assisted Therapy

Via Benzinga

Ketamine Therapy At Your Doorstep, Growing Number Of Clinics Offer This Treatment Option

October 05, 2022

Being the sole psychedelic legally available as medicine, ketamine-assisted therapy services are expanding at a rapid pace across the U.S.

Via Benzinga

Great Psychedelics And Business Events Are Coming In Q4: Check Them Out Here

September 13, 2022

The season for psychedelics conferences is right around the corner. From very large and well-known events to small meets, this year’s remaining months are loaded with on-site and virtual discussions...

Via Benzinga

4 Psychedelics Companies Post Financial Results: Learn How Field Trip, Wesana, Braxia and Irwin Naturals Performed

August 30, 2022

Field Trip (NASDAQ: FTRP), Wesana (OTCQB: WSNAF), Braxia (OTC: BRAXF) and

Via Benzinga

Telehealth Market News: Braxia Scientific Enters Industry By Acquiring Ketamine Treatment Platform In Florida

August 03, 2022

A researcher and provider of ketamine-assisted treatments for mental health conditions, Braxia Scientific Corp.

Via Benzinga

Braxia Scientific Fiscal 2022 Revenue Grows 47.5% YoY, What About Net Loss?

August 01, 2022

Braxia Scientific Corp. (OTCPK:BRAXF) (CSE:RAX) (FWB:4960) recorded revenue of $1.49 million for the fiscal 2022 year ended March 31, 2022 compared with revenue of $1.008 million for the year ended...

Via Benzinga

Canadian Special Access Program Further Authorizes Novel Psychedelic Drugs For Emergency Treatments

June 16, 2022

For those unaware, Canada provides a legal way for patients presenting unresolved mental health issues to receive psychedelic-assisted treatment.

Via Benzinga

Braxia Opens New Clinic in Ontario, Facilitating Further Access To Ketamine And Psilocybin Treatments

June 15, 2022

Braxia Scientific Corp.

Via Benzinga

These 18 Clinical Trials Could Shape The Future Of The Psychedelics Industry

June 02, 2022

In the nascent industry of medical psychedelics, drug development is the name of the game. This subset of biotech, poised to become a $100 billion industry according to Canaccord Genuity, bases its...

Via Benzinga

Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation

October 18, 2021

The Week In Psychedelics

Via Benzinga

Psyched: Elon Musk Discusses Psychedelics, Delix Raises $70M, MindCure To Study MDMA In Female Sexual Dysfunction

October 04, 2021

The Week In Psychedelics:

Via Benzinga

There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are

October 13, 2021

Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S...

Via Benzinga

< Previous 1 2 Next >

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.